|
US4235871A
(en)
|
1978-02-24 |
1980-11-25 |
Papahadjopoulos Demetrios P |
Method of encapsulating biologically active materials in lipid vesicles
|
|
US4501728A
(en)
|
1983-01-06 |
1985-02-26 |
Technology Unlimited, Inc. |
Masking of liposomes from RES recognition
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US5019369A
(en)
|
1984-10-22 |
1991-05-28 |
Vestar, Inc. |
Method of targeting tumors in humans
|
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
US4837028A
(en)
|
1986-12-24 |
1989-06-06 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
US5180806A
(en)
*
|
1988-05-16 |
1993-01-19 |
The Scripps Research Institute |
Polypeptides and compositions of human papillomavirus latent proteins, diagnostic systems and methods
|
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
|
SE9001705D0
(sv)
*
|
1990-05-11 |
1990-05-11 |
Medscand Ab |
Saett foer diagnostik av virusbaerande tumoerer genom immunoassay
|
|
US5789650A
(en)
|
1990-08-29 |
1998-08-04 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
US5770429A
(en)
|
1990-08-29 |
1998-06-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
ATE300615T1
(de)
|
1990-08-29 |
2005-08-15 |
Genpharm Int |
Transgene mäuse fähig zur produktion heterologer antikörper
|
|
US5877397A
(en)
|
1990-08-29 |
1999-03-02 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
US5874299A
(en)
|
1990-08-29 |
1999-02-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5814318A
(en)
|
1990-08-29 |
1998-09-29 |
Genpharm International Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
ES2136092T3
(es)
|
1991-09-23 |
1999-11-16 |
Medical Res Council |
Procedimientos para la produccion de anticuerpos humanizados.
|
|
US6037135A
(en)
*
|
1992-08-07 |
2000-03-14 |
Epimmune Inc. |
Methods for making HLA binding peptides and their uses
|
|
FR2794370B1
(fr)
*
|
1999-06-03 |
2003-10-17 |
Biovector Therapeutics |
Fragments proteiques polyepitopiques, leur obtention et leurs utilisations notamment en vaccination
|
|
US7026443B1
(en)
*
|
1999-12-10 |
2006-04-11 |
Epimmune Inc. |
Inducing cellular immune responses to human Papillomavirus using peptide and nucleic acid compositions
|
|
FR2824326B1
(fr)
*
|
2001-05-04 |
2004-03-19 |
Commissariat Energie Atomique |
Melange de peptides issus des proteines e6 et/ou e7 de papillomavirus et leurs applications
|
|
US20040171081A1
(en)
*
|
2001-11-23 |
2004-09-02 |
Abraham Mittelman |
Antigens
|
|
WO2003057171A2
(en)
|
2002-01-03 |
2003-07-17 |
The Trustees Of The University Of Pennsylvania |
Activation and expansion of t-cells using an engineered multivalent signaling platform
|
|
CA2484941A1
(en)
*
|
2002-07-24 |
2004-02-05 |
Intercell Ag |
Antigens encoded by alternative reading frame from pathogenic viruses
|
|
WO2004105681A2
(en)
*
|
2003-04-28 |
2004-12-09 |
Innogenetics N.V. |
Cd4+ human papillomavirus (hpv) epitopes
|
|
JP5030594B2
(ja)
*
|
2003-12-23 |
2012-09-19 |
アルボー ビータ コーポレーション |
Ｈｐｖの発癌性株に対する抗体およびそれらの使用方法
|
|
JP2007528838A
(ja)
*
|
2003-12-24 |
2007-10-18 |
ライデン ユニバーシティ メディカル センター |
腫瘍特異的ワクチンとしての合成タンパク質
|
|
AU2005222776A1
(en)
*
|
2003-12-31 |
2005-09-29 |
Genimmune N.V. |
Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions
|
|
US8252893B2
(en)
*
|
2005-01-31 |
2012-08-28 |
Board Of Trustees Of The University Of Arkansas |
CD8 T cell epitopes in HPV 16 E6 and E7 proteins and uses thereof
|
|
WO2008092854A2
(en)
*
|
2007-01-30 |
2008-08-07 |
Transgene S.A. |
Papillomavirus e2 polypeptide used for vaccination
|
|
EP2167137B1
(en)
*
|
2007-05-31 |
2013-10-16 |
GENimmune N.V. |
Hpv polyepitope constructs and uses thereof
|
|
GB0710538D0
(en)
*
|
2007-06-01 |
2007-07-11 |
Glaxo Group Ltd |
Vaccine
|
|
CN104769104A
(zh)
|
2011-12-12 |
2015-07-08 |
细胞药物有限公司 |
扩大t细胞的方法
|
|
AU2013208364B2
(en)
*
|
2012-01-13 |
2017-10-26 |
Apo-T B.V. |
Aberrant cell-restricted immunoglobulins provided with a toxic moiety
|
|
EP2883550A1
(en)
*
|
2013-12-12 |
2015-06-17 |
Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts |
Novel promiscuous HPV16-derived T helper epitopes for immunotherapy
|
|
SG11201707540QA
(en)
*
|
2015-03-16 |
2017-10-30 |
Max-Delbrück-Centrum Für Molekulare Medizin In Der Helmholtz-Gemeinschaft |
Method of detecting new immunogenic t cell epitopes and isolating new antigen-specific t cell receptors by means of an mhc cell library
|
|
KR20190020098A
(ko)
*
|
2016-06-20 |
2019-02-27 |
아이에스에이 파마슈티컬즈 비.브이. |
펩타이드 백신의 제형
|
|
WO2019173465A1
(en)
*
|
2018-03-06 |
2019-09-12 |
Intrexon Corporation |
Human papillomavirus vaccines and uses of the same
|